Study of 2-min walk test and 15-step exercise oximetry test in the assessment of exercise tolerance in Egyptian patients with chronic obstructive pulmonary disease  by Negm, Medhat F. et al.
Egyptian Journal of Chest Diseases and Tuberculosis (2012) 61, 291–296The Egyptian Society of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis
www.elsevier.com/locate/ejcdt
www.sciencedirect.comORIGINAL ARTICLEStudy of 2-min walk test and 15-step exercise oximetry
test in the assessment of exercise tolerance in Egyptian
patients with chronic obstructive pulmonary diseaseMedhat F. Negm, Mohamed E. Abdalla *, Mohamed A. AlmahdyDepartment of Chest, Benha Faculty of Medicine, EgyptReceived 25 July 2012; accepted 10 August 2012
Available online 23 January 2013*
E-
Pe
04
OpKEYWORD
COPDCorresponding author. Tel.:
mail address: mabdalla66@y
er review under responsibilit
Production an
22-7638 ª 2012 The Egyptia
en access under CC BY-NC-ND li+20 127
ahoo.com
y of The
d hostin
n Society
httpcense.Abstract Purpose: The present study was conducted to study the 2-min walk test and 15-step
exercise oximetry test in determination of exercise tolerance in Egyptian patients with chronic
obstructive pulmonary disease.
Methods: Sixty male patients with COPD were included in this study who were divided into
three groups (mild, moderate and severe). All of the patients were subjected cardio pulmonary exer-
cise test using ramp protocol, 6 min walk test, 2-min walk test and 15 step exercise oximetry test.
Results: In this study we found signiﬁcant difference between mild, moderate and severe groups as
regards VO2% predicted, distance walked during 6-MWT, distance walked during 2-MWT, and sat-
uration difference % and exercise time/s during 15-step exercise oximetry test (p value <0.05).We
found also signiﬁcant correlation between 2-MWT and 6-MWT and VO2 in the mild, moderate
and severe groups. (r= 0.9 and 0.85, respectively for the mild, r= 0.52 and 0.48, respectively for
the moderate and r= 0.94 and 0.45, respectively for the severe p<0.05 for all). We did not ﬁnd such
correlation between exercise time in 15-step exercise oximetry test and both 6-MWT and VO2 in the
three groups. (r= 0.066 and 0.067, respectively for the mild, r= 0.08 and 0.07, respectively
for the moderate and r= 0.07 and0.021, respectively for the severe, P> 0.05 for all). Also there
was non-signiﬁcant correlation between saturation difference in 15-step exercise oximetry test and
both 6-MWT and VO2 in the three groups(r= 0.371 and 0.378, respectively for the mild,
r= 0.086 and 0.061, respectively for the moderate and r= 0.051 and 0.013, respectively
for the severe p> 0.05 for all).
Conclusions: The study shows that the 2MWT is a valid test for the assessment of exercise capacity
in patients with COPD. It is practical, simple, and well-tolerated by patients with severe COPD.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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(M.E. Abdalla).
Egyptian Society of Chest Diseases and Tuberculosis.
g by Elsevier
of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
://dx.doi.org/10.1016/j.ejcdt.2012.08.014
292 M.F. Negm et al.Introduction
Chronic obstructive pulmonary disease is a preventable and
treatable disease with some signiﬁcant extrapulmonary effects
that may contribute to the severity in individual patients. Its
pulmonary component is characterized by airﬂow limitation
that is not fully reversible. The airﬂow limitation is usually
progressive and associated with an abnormal inﬂammatory re-
sponse of the lung to noxious particles or gases [1].
Several tests are available for the evaluation of functional
capacity in patients with chronic lung diseases. These include
the cardiopulmonary exercise test [2]. The CPXT is considered
the gold standard but it is more expensive than other tests that
were proven useful for clinical purposes [3,4]. In the past few
years, walk tests have gained prominence in both clinical prac-
tice and research.
These tests are used for measuring functional capacity,
monitoring treatment effectiveness, and establishing prognosis
[5]. The most commonly used timed walk tests are the 6-min
walk test (6MWT) and the 12-min walk test (12MWT). Sub-
jects are instructed to walk as much as possible in the allotted
time period. Both tests have been quite extensively evaluated,
and have been shown to be reliable and valid in reﬂecting
the exercise capacity in COPD patients [3,6]. It was argued that
the distance covered in a 2-min interval of a 12MWT might be
different from the distance walked in a 2MWT, as the pacing
by the subjects might be different for the two different inter-
vals. It was reported that a patient who knew that a walk test
would only last for 2 min would walk further than a patient
would in the ﬁrst 2 min of a longer walk test [7]. A 2-min walk
test (2MWT) was ﬁrst proposed by Butland et al. [8] and was
reported to be a valid test in COPD patients. A more recent
study by Eiser et al. [9] reported that the 2MWT was a reliable
test and was sensitive to change after bronchodilator therapy.
The 15-steps climbing test oximetry has been found useful for
estimating ventilatory reserve in patients with chronic obstruc-
tive pulmonary disease (COPD) and for predicting postopera-
tive complications of lung resection. A good correlation has
been found with PFTs. Several studies have also found it effec-
tive for assessing arterial hypoxemia and recommended its use
as a marker of disease severity and the need for oxygen supple-
mentation (Victorya et al. [10]).Aim of the work
The aim of this study was to correlate the ﬁnding of cardiopul-
monary exercise test as regarding VO2 to those of 2-min walk
test and 15-step exercise oximetry test and to determine
whether reliable functional capacity data can be obtained at
a lower cost in Egyptian patients with chronic obstructive pul-
monary disease.Subjects and methods
Sixty male patients with mild to severe COPD were included in
this study during the period from October 2008 to May 2011.
The study protocol was approved by the local ethics commit-
tee. Informed consent was obtained from the patients.
All patients were attendant or came for follow up in Benha
University outpatient clinic. Their age ranged from 36 to
75 years and all of them were cigarette smokers. The diagnosisof these patients was made according to the recommendations
of GOLD, 2008 [11].
The inclusion criteria included the following: (1) mild-to-se-
vere COPD; (2) stable condition without experiencing an acute
exacerbation in the month prior to or during the study; (3) no
change in medication during the study; and (4) no requirement
for long-term oxygen therapy [12].
The exclusion criteria included the following: Dementia,
concomitant heart failure, diseases with mobility impairment,
and medical conditions that were contraindicated for exercise
testing according to American Thoracic Society guidelines
including unstable angina and acute ECG changes suggestive
of myocardial infarction [13].
The patients were divided into three groups according to
criteria of GOLD [11]:
1. Mild COPD (20 patients): FEV1/FVC< 70% and FEV1P
80% predicted.
2. Moderate COPD (20 patients): FEV1/FVC < 70% and
50% 6 FEV1 < 80% predicted.
3. Severe COPD (20 patients): FEV1/FVC< 70% and 30% 6
FEV1 < 50% predicted.
All patients were subjected to the following: thorough med-
ical history and clinical examination, Plain chest X-ray (poste-
ro-anterior and lateral views), complete blood count, liver
function tests, kidney function tests and ECG. Also all subjects
underwent pulmonary function testing; including resting spi-
rometry included ﬂow volume loop and Maximal Voluntary
Ventilation (MVV) [14], measurement of lung volumes [15]
and diffusing capacity for carbon monoxide (DLCO) using
single breath technique [16] which were performed using com-
puterized equipment (V. Max 225 Auto box) sensor medics
system. Ambient temperature and pressure were entered with
the patient data (age in years, weight in kilograms, height in
centimeters and sex) so that all results were calculated as per-
cent of predicted except for FEV1/FVC%.
Cardio pulmonary exercise test: A symptom limited maxi-
mal incremental exercise testing was done using an Ergometer,
Jaeger, Oxycon Delta, Medizintechinck mit system, Miyn-
hardt. Protocol for exercise testing [17].
Six-minute walk test [13]: The test was conducted between
10 a.m. and 4 p.m. for all patients. A thirty-meter ﬂat, obsta-
cle-free corridor with a chair placed at either end was used. Pa-
tients were instructed to walk as far as possible to cover the
longest possible distance over 6 min under supervision.
Patient preparation:
1. Comfortable clothing should had been worn.
2. The patient usual medical regimen should had been contin-
ued (if present).
3. A light meal was acceptable at least 2 h before the test.
4. Patients should not had exercised vigorously within 2 h of
beginning of the test.
Measurement of 6-min walk test:
1. The test was performed twice about the same time of the
day to minimize intraday variability and the best result
was reported.
2. A ‘‘warm-up’’ period before the test should not be
performed.
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ing point.
4. The patient was instructed as follows:
The object of this test is to walk as far as possible for 6 min
through walking back and forth in this hallway. You are per-
mitted to slow down, to stop and to rest as necessary. You may
lean against the wall while resting, but resume walking as soon
as you can. The patient was then asked ‘‘are you ready to do
that?’’
5. As soon as the patient started to walk the timer was
started.
6. After the ﬁrst minute the patient was told ‘‘you were
doing well. You had 5 min to go’’. When the timer
shows 4 min remaining the patient was told’’ keep up
the good work. You had 4 min to go’’. When the timer
shows 3 min remaining the patient was told ‘‘you were
doing well. You are halfway done’’. When the timer
shows 2 min remaining the patient was told ‘‘keep up
the good work. You have only 2 min left’’. When the
timer shows 1 min remaining the patient was told
‘‘you are doing well. You have only 1 min to go’’. Other
words of encouragement (or body language to speed up)
were not used.
7. If the patient stopped walking during the test and
needed to rest, he was told ‘‘you could lean against
the wall if you would like; then continue walking when-
ever you feel able’’. The timer was not stopped.
8. If the patient stopped before the 6 min were up and
refused to continue, the patient is allowed to set on
the chair and the time of stopping as well as the distance
walked was recorded.
9. When the 6 min were over the patient was told to stop
and piece of tape was used to mark the spot where he
was stopped.
10. Calculation of the distance walked was done by using
number of laps multiplied by 60 plus the number of
meters in the ﬁnal partial lap (using the markers on
the corridor), rounding it to the nearest meter.
11. Congratulation of the patient for good effort was done.
12. Two-minute walk test [18]: The same as 6-MWT but the
patient was allowed to walk for 2 min only.Table 1 Demographic data and pulmonary function.*
Variables Values =Mean ± S.D.
Mild (n= 20)
Age/years 43.2500 ± 5.29026
SI 455.00 ± 94.45132
Duration of illness/years 3.8500 ± 0.98809
FEV1/FVC 66.6500 ± 1.30888
FEV1% predicted post BD 85.5000 ± 3.28473
FEV1% change post BD 3.1500 ± 1.72520
TLC% predicted 98.3500 ± 2.10950
RV/TLC% 22.3500 ± 2.00722
DLCO% predicted 89.6500 ± 4.89118
SI = smoking index; FEV1 = forced expiratory volume in the ﬁrst second
volume; TLC= total lung capacity; Dlco = diffusion capacity of the lun13. Step exercise oximetry test [19]: Patient preparation:
The same as that of 6-MWT
Test procedure: A ﬁnger oximeter (MEK, MP10, USA)
with continuous recording of heart rate and oxygen saturation
was connected to each patient. A step measuring 25 · 25 ·
20 cm was used. Patients were asked to climb up and down
the step 15 times as fast as they could (without any ﬁxed
pacing). Each test was repeated twice, and the mean value
was taken. The time of exercise was recorded (exercise time).
Baseline oxygen saturation and the lowest saturation were
recorded as well. All the results were collected, tabulated and
statistically analyzed.
Statistical analysis
Statistical Analysis was performed using the computer pro-
gram SPSS (Statistical package for social science) version 16.
To compare two independent samples we used an unpaired
t-test. ANOVA (analysis of variance) used to compare between
more than two groups of numerical (parametric) data. Pearson
correlation coefﬁcient test was used correlating different
parameters. Inter-group comparison of categorical data was
performed by using chi square test (X2-value). A P value
<0.05 was considered statistically signiﬁcant (S) and a P value
<0.0001 was considered highly signiﬁcant (HS) in all analyses.
Results
These tables Tables 1–4 shows that there was signiﬁcant corre-
lation between 2-MWT and 6-MWT and VO2% predicted in
the mild, moderate and severe groups.
Discussion
Different exercise tests are used to evaluate the functional
capacity in chronic obstructive pulmonary disease. The cardio-
pulmonary exercise test is considered the gold standard [20].
Functional walk tests are exercise tests that measure functional
status or capacity, mainly the ability to undertake physically
demanding activities of daily living [21]. They are considered
objectivemeasures that provide ameans ofmonitoring response
to treatment [22]. Compared to traditional laboratory indexesModerate (n= 20) Severe (n= 20)
55.8000 ± 5.50215 65.5500 ± 6.45205
1060.00 ± 218.6080 1325.00 ± 222.1308
10.6500 ± 9.37676 18.7500 ± 4.78897
60.1500 ± 7.58999 55.8500 ± 3.85630
61.6000 ± 6.34450 42.3500 ± 5.14296
4.3000 ± 2.57723 1.8000 ± 1.47256
103.9500 ± 7.23642 125.6000 ± 9.38868
25.9500 ± 5.27631 33.1500 ± 4.93404
75.1500 ± 11.82448 66.2500 ± 5.88374
; FVC= forced vital capacity; BD= bronchodilator; RV = residual
g for carbon monoxide.
Table 4 Comparison between different groups as regards distance walked (/meter) during the 2-MWT.
No. Mean ±S.D. Range f p Between groups
Distance walked Mild 20 163.0000 20.79980 130–200 61.9 <0.05 P1 < 0.05
Moderate 20 119.8000 17.72183 90–150 P2 < 0.05
Severe 20 98.45 17.361 70–125 P3 < 0.05
P value >0.05 = non-signiﬁcant. P value <0.05 = signiﬁcant. P value <0.05 = highly signiﬁcant.
Table 5 Comparison between different groups as regards parameters of 15-step exercise oximetry test (saturation difference% and
exercise time/s.
No. Mean ±S.D. Range f P Between groups
Saturation diﬀerence Mild 20 .6000 .50262 0–1 61.6 <0.05 P1 < 0.05
Moderate 20 2.1000 .71818 1–3 P2 < 0.05
Severe 20 5.0000 2.02614 3–9 P3 < 0.05
Exercise time Mild 20 33.5000 6.20272 21–45 135.4 <0.05 P1 < 0.05
Moderate 20 55.2000 6.57427 45–65 P2 < 0.05
Severe 20 69.1000 7.80621 58–80 P3 < 0.05
P value >0.05 = non-signiﬁcant. P value <0.05 = signiﬁcant. P value <0.05 = highly signiﬁcant.
Table 6 Correlation between 2-MWT and 6-MWT and
VO2% predicted:
Mild Moderate Severe
r p r p r P
6-MWT 0.9 <0.05 0.524 <0.05 0.945 <0.05
VO2% pred. 0.855 <0.05 0.485 <0.05 0.458 <0.05
P value > 0.05 = non-signiﬁcant. P value <0.05 = signiﬁcant. P
value <0.05 = highly signiﬁcant.
Table 3 Comparison between different groups as regards distance walked (/meter) during the 6-MWT.
No. Mean ±S.D. Range f p Between groups
Distance walked Mild 20 426.0000 69.31241 340–580 3.6 <0.05 P1 < 0.05
Moderate 20 308.0000 85.115 200–385 P2 < 0.05
Severe 20 196.1500 37.73352 150–270 P3 < 0.05
P value >0.05 = non-signiﬁcant. P value <0.05 = signiﬁcant. P value <0.05 = highly signiﬁcant.
Table 2 Comparison between different groups as regards CPET parameter (VO2% predicted).
No. Mean ±S.D. Range F p Between groups
VO2% pred. Mild 20 82.3000 6.54619 75–95 162.8 <0.05 P1 < 0.05
Moderate 20 61.1500 7.30735 50–75 P2 < 0.05
Severe 20 44.9000 5.77563 35–55 P3 < 0.05
P value >0.05 = non-signiﬁcant. P value <0.05 = signiﬁcant. P value <0.05 = highly signiﬁcant.
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walk tests require less technical expertise and equipment, mak-
ing them inexpensive and easy to administer [23].
In our study we found that There was signiﬁcant difference
between mild, moderate and severe groups as regards VO2%
predicted (Means ± SD, 82.3 ± 6.54, 61.15 ± 7.3, 44.9 ±
5.77, respectively, P value <0.05). This indicates that with
increasing severity of COPD there is progressive decrease in
VO2% predicted. These results match with those of Go¨khan
et al. [24] who revealed that exercise capacity correlates with
FEV1 and the degree of disease severity in stable COPD pa-
tients. Also, there was signiﬁcant difference between mild,
moderate and severe groups as regards distance walked during
6-MWT (The distance walked/meter (Means ± SD) were,
426 ± 69.3, 308 ± 85.115, and 196.15 ± 37.73, respectively).
This means that there is progressive decrease in distance
walked during 6-MWT with increasing severity of COPD.
These results are in agreement with those of Martijn et al.[25]. Who found that severe airﬂow limitation by GOLD stage
is a signiﬁcant clinical determinant of poor 6MWD perfor-
mance. There was signiﬁcant difference between the mild,
moderate and severe groups as regards distance walked during
2-MWT (Means ± SD were163 ± 20.79, 119.8 ± 17.72, and
98.45 ± 17.361 meter, respectively, P value <0.05). This indi-
Table 7 Correlation between exercise time (/seconds) in 15-step exercise oximetry test and both 6-MWT and VO2% predicted in the
three groups.
Mild Moderate Severe
r p r p r p
6-MWT 90.0668 >0.05 0.085 >0.05 0.0760 >0.05
VO2% pred. 0.0673 >0.05 0.0701 >0.05 0.218 >0.05
P value >0.05 = non-signiﬁcant. P value <0.05 = signiﬁcant. P value <0.05 = highly signiﬁcant.
Table 8 Correlation between saturation difference % in 15-step exercise oximetry test and both 6-MWT and VO2% predicted in the
three groups.
Mild Moderate Severe
r p r p R p
6-MWT 0.371 >0.05 0.086 >0.05 0.0514 >0.05
VO2% pred. 0.378 >0.05 0.0615 >0.05 0.013 >0.05
P value >0.05 = non-signiﬁcant. P value <0.05 = signiﬁcant. P value <0.05 = highly signiﬁcant.
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ing 2-MWT with increasing severity of COPD. These results
are in agreement with those of Butland et al. [8] who validated
the 2MWT as a similar measure of exercise tolerance as the
6MWT and 12MWT in patients with COPD. Table 5 showed
that there is signiﬁcant difference between the mild, moderate
and severe groups as regards saturation difference % (Mean ±
SD were 0.6 ± 0.5, 2.1 ± 0.71, and 5 ± 2.02, respectively,
p value <0.05) and exercise time/s (Mean ± SD were
33.5 ± 6.2, 55.2 ± 6.57, and 69.1 ± 7.8, respectively, p value
<0.05). It means that desaturation during 15-step exercise
oximetry test as well as exercise time both increase with
increasing severity of COPD. These results are in agreement
with those of Daniel et al. [19] who revealed that there was sig-
niﬁcant difference between mild, moderate and severe groups
as regards saturation difference and exercise time. Table 6
showed correlation between 2-MWT and 6-MWT and VO2.
There was signiﬁcant correlation between 2-MWT and 6-
MWT and VO2 in the mild, moderate and severe groups.
These results match with those of Amy et al. [12]. The signiﬁ-
cant correlations between the 2MWT and VO2 support the
validity of the 2MWT as a measure of exercise capacity in
COPD patients with mild-to-severe disease. The strongest cor-
relation was observed between the 2MWT and 6MWT, since
they are both walking tests and their results were in agreement
with those of previous studies. (Butland et al. [8]; Bernstein et
al. [26]. Table 7 shows that there is non-signiﬁcant correlation
between exercise time in 15-step exercise oximetry test and
both 6-MWT and VO2 in the three groups. These results are
in agreement with those of Daniel et al. [19] who found that
there was no correlation noted between the 15 step exercise
oximetry test result (exercise time) and either the CPET or
the 6 min walk. Table 8 shows that there is non-signiﬁcant cor-
relation between saturation difference and both 6-MWT and
VO2 in the three groups. These results match with those of
Daniel et al. [19] who found that there was no correlation
noted between the 15 step exercise oximetry test result (satura-
tion difference) and either the CPET or the 6 min walk. These
results were not match with those of Victorya et al. [10] whosayed that there was a statistically signiﬁcant correlation be-
tween all parameters of the 15-steps climbing test and both
VO2 on the CPET, and carbon monoxide diffusion in the
lungs (DLCO). The difference between the current and the pre-
vious study may be due to difference as regarding patient
characteristics.In conclusion
The 2MWT was shown to be valid test for the assessment of
exercise capacity in patients with COPD. It is practical, simple,
and well-tolerated by patients with severe COPD. The 15 step
exercise oximetry test had no correlation to the CPET or to the
6MWT in patients with COPD. Further studies on large scales
is recommended.References
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